These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33991627)

  • 1. Discovery of a new class of JMJD6 inhibitors and structure-activity relationship study.
    Wang T; Zhang R; Liu Y; Fang Z; Zhang H; Fan Y; Yang S; Xiang R
    Bioorg Med Chem Lett; 2021 Jul; 44():128109. PubMed ID: 33991627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of JMJD7 inhibitors with the aid of virtual screening and bioactivity evaluation.
    Zhang W; Li K; Wang T; Wu M; Li L
    Bioorg Med Chem Lett; 2021 Aug; 45():128139. PubMed ID: 34048880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of a Highly Selective Cell-Active Inhibitor of the Histone Lysine Demethylases KDM2/7.
    Gerken PA; Wolstenhulme JR; Tumber A; Hatch SB; Zhang Y; Müller S; Chandler SA; Mair B; Li F; Nijman SMB; Konietzny R; Szommer T; Yapp C; Fedorov O; Benesch JLP; Vedadi M; Kessler BM; Kawamura A; Brennan PE; Smith MD
    Angew Chem Int Ed Engl; 2017 Dec; 56(49):15555-15559. PubMed ID: 28976073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of JMJD6 by 2-Oxoglutarate Mimics.
    Islam MS; Thinnes CC; Holt-Martyn JP; Chowdhury R; McDonough MA; Schofield CJ
    ChemMedChem; 2022 Jan; 17(1):e202100398. PubMed ID: 34581506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cell-permeable ester derivative of the JmjC histone demethylase inhibitor IOX1.
    Schiller R; Scozzafava G; Tumber A; Wickens JR; Bush JT; Rai G; Lejeune C; Choi H; Yeh TL; Chan MC; Mott BT; McCullagh JS; Maloney DJ; Schofield CJ; Kawamura A
    ChemMedChem; 2014 Mar; 9(3):566-71. PubMed ID: 24504543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of a potent and selective inhibitor of histone lysine demethylase KDM4D.
    Fang Z; Liu Y; Zhang R; Chen Q; Wang T; Yang W; Fan Y; Yu C; Xiang R; Yang S
    Eur J Med Chem; 2021 Nov; 223():113662. PubMed ID: 34237635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell Penetrant Inhibitors of the KDM4 and KDM5 Families of Histone Lysine Demethylases. 1. 3-Amino-4-pyridine Carboxylate Derivatives.
    Westaway SM; Preston AG; Barker MD; Brown F; Brown JA; Campbell M; Chung CW; Diallo H; Douault C; Drewes G; Eagle R; Gordon L; Haslam C; Hayhow TG; Humphreys PG; Joberty G; Katso R; Kruidenier L; Leveridge M; Liddle J; Mosley J; Muelbaier M; Randle R; Rioja I; Rueger A; Seal GA; Sheppard RJ; Singh O; Taylor J; Thomas P; Thomson D; Wilson DM; Lee K; Prinjha RK
    J Med Chem; 2016 Feb; 59(4):1357-69. PubMed ID: 26771107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based design and discovery of potent and selective KDM5 inhibitors.
    Nie Z; Shi L; Lai C; O'Connell SM; Xu J; Stansfield RK; Hosfield DJ; Veal JM; Stafford JA
    Bioorg Med Chem Lett; 2018 May; 28(9):1490-1494. PubMed ID: 29627262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of pyrazolo[1,5-a]pyrimidine-3-carbonitrile derivatives as a new class of histone lysine demethylase 4D (KDM4D) inhibitors.
    Fang Z; Wang TQ; Li H; Zhang G; Wu XA; Yang L; Peng YL; Zou J; Li LL; Xiang R; Yang SY
    Bioorg Med Chem Lett; 2017 Jul; 27(14):3201-3204. PubMed ID: 28539219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C8-substituted pyrido[3,4-d]pyrimidin-4(3H)-ones: Studies towards the identification of potent, cell penetrant Jumonji C domain containing histone lysine demethylase 4 subfamily (KDM4) inhibitors, compound profiling in cell-based target engagement assays.
    Le Bihan YV; Lanigan RM; Atrash B; McLaughlin MG; Velupillai S; Malcolm AG; England KS; Ruda GF; Mok NY; Tumber A; Tomlin K; Saville H; Shehu E; McAndrew C; Carmichael L; Bennett JM; Jeganathan F; Eve P; Donovan A; Hayes A; Wood F; Raynaud FI; Fedorov O; Brennan PE; Burke R; van Montfort RLM; Rossanese OW; Blagg J; Bavetsias V
    Eur J Med Chem; 2019 Sep; 177():316-337. PubMed ID: 31158747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compounds and methods for inhibiting histone demethylases: a patent evaluation of US20160102096A1.
    Thaler F; Mercurio C
    Expert Opin Ther Pat; 2016 Dec; 26(12):1367-1370. PubMed ID: 27730846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based mapping of the histone-binding pocket of KDM4D using functionalized tetrazole and pyridine core compounds.
    Małecki PH; Fassauer GM; Rüger N; Schulig L; Link A; Krylova O; Heinemann U; Weiss MS
    Eur J Med Chem; 2024 Oct; 276():116642. PubMed ID: 38981336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic structure and expression of Jmjd6 and evolutionary analysis in the context of related JmjC domain containing proteins.
    Hahn P; Böse J; Edler S; Lengeling A
    BMC Genomics; 2008 Jun; 9():293. PubMed ID: 18564434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of N-(1-(6-(substituted phenyl)-pyridazin-3-yl)-piperidine-3-yl)-amine derivatives as JMJD6 inhibitors.
    Qian Y; Ao M; Li B; Kuang Z; Wang X; Cao Y; Li J; Qiu Y; Guo K; Fang M; Wu Z
    Bioorg Chem; 2022 Dec; 129():106119. PubMed ID: 36116323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel 5-carboxy-8-HQ based histone demethylase JMJD2A inhibitors: introduction of an additional carboxyl group at the C-2 position of quinoline.
    Feng T; Li D; Wang H; Zhuang J; Liu F; Bao Q; Lei Y; Chen W; Zhang X; Xu X; Sun H; You Q; Guo X
    Eur J Med Chem; 2015 Nov; 105():145-55. PubMed ID: 26491978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of cyanopyridine scaffold as novel indoleamine-2,3-dioxygenase 1 (IDO1) inhibitors through virtual screening and preliminary hit optimisation.
    Xu X; Ren J; Ma Y; Liu H; Rong Q; Feng Y; Wang Y; Cheng Y; Ge R; Li Z; Bian J
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):250-263. PubMed ID: 30734612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetrazolylhydrazides as Selective Fragment-Like Inhibitors of the JumonjiC-Domain-Containing Histone Demethylase KDM4A.
    Rüger N; Roatsch M; Emmrich T; Franz H; Schüle R; Jung M; Link A
    ChemMedChem; 2015 Nov; 10(11):1875-83. PubMed ID: 26337137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitor scaffold for the histone lysine demethylase KDM4C (JMJD2C).
    Leurs U; Clausen RP; Kristensen JL; Lohse B
    Bioorg Med Chem Lett; 2012 Sep; 22(18):5811-3. PubMed ID: 22917519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small molecule KDM4s inhibitors as anti-cancer agents.
    Lin H; Li Q; Li Q; Zhu J; Gu K; Jiang X; Hu Q; Feng F; Qu W; Chen Y; Sun H
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):777-793. PubMed ID: 29651880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-Based Screening of Tetrazolylhydrazide Inhibitors versus KDM4 Histone Demethylases.
    Małecki PH; Rüger N; Roatsch M; Krylova O; Link A; Jung M; Heinemann U; Weiss MS
    ChemMedChem; 2019 Nov; 14(21):1828-1839. PubMed ID: 31475772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.